Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Revista Espanola De Enfermedades Digestivas
|
February 22, 2021
Clinical impact of endoscopic ultrasound in the study of adrenal gland: cytomegalovirus infection mimicking a neoplasic hypercaptation in PET
Albert Martín-Cardona, Ferran Vall-Llovera Calmet, Clarisa González Mínguez, et al.
Haematologica
|
January 2, 2008
Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART
José-Tomás Navarro, Ferran Vall-Llovera, José-Luis Mate, et al.
Medicina Clinica
|
November 17, 2007
[Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases]
Montserrat Batlle, Ferran Vall-Llovera, Jordi Bechini, et al.
Leukemia & Lymphoma
|
January 18, 2013
Pharmacogenetic analysis in the treatment of Hodgkin lymphoma
Albert Altés, Laia Paré, Albert Esquirol, et al.
Oncotarget
|
May 4, 2018
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine
Marta Cabezón, Joan Bargay, Blanca Xicoy, et al.
Blood Cancer Journal
|
May 5, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
Guadalupe Oñate, Marta Pratcorona, Ana Garrido, et al.
Cancer
|
January 31, 2013
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab)
Josep-Maria Ribera, Olga García, Carlos Grande, et al.
Blood Cancer Journal
|
January 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Guadalupe Oñate, Ana Garrido, Montserrat Arnan, et al.
British Journal of Haematology
|
June 9, 2020
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease
Alex Bataller, Guadalupe Oñate, Marina Diaz-Beyá, et al.
European Journal of Haematology
|
September 5, 2022
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics
Johana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Revista Espanola De Enfermedades Digestivas
|
February 22, 2021
Clinical impact of endoscopic ultrasound in the study of adrenal gland: cytomegalovirus infection mimicking a neoplasic hypercaptation in PET
Albert Martín-Cardona, Ferran Vall-Llovera Calmet, Clarisa González Mínguez, et al.
Haematologica
|
January 2, 2008
Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART
José-Tomás Navarro, Ferran Vall-Llovera, José-Luis Mate, et al.
Medicina Clinica
|
November 17, 2007
[Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases]
Montserrat Batlle, Ferran Vall-Llovera, Jordi Bechini, et al.
Leukemia & Lymphoma
|
January 18, 2013
Pharmacogenetic analysis in the treatment of Hodgkin lymphoma
Albert Altés, Laia Paré, Albert Esquirol, et al.
Oncotarget
|
May 4, 2018
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine
Marta Cabezón, Joan Bargay, Blanca Xicoy, et al.
Blood Cancer Journal
|
May 5, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
Guadalupe Oñate, Marta Pratcorona, Ana Garrido, et al.
Cancer
|
January 31, 2013
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab)
Josep-Maria Ribera, Olga García, Carlos Grande, et al.
Blood Cancer Journal
|
January 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Guadalupe Oñate, Ana Garrido, Montserrat Arnan, et al.
British Journal of Haematology
|
June 9, 2020
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease
Alex Bataller, Guadalupe Oñate, Marina Diaz-Beyá, et al.
European Journal of Haematology
|
September 5, 2022
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics
Johana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, et al.
Page
of 3